FIELD: medicine; pharmaceutics.
SUBSTANCE: invention relates to a method of producing tablets containing N-benzyl-N-methyl-1-phenylpyrrolo[1,2-α]pyrazine-3-carboxamide as an active substance, as well as excipients acceptable in pharmaceutical technology. Method of producing the tabletted form of N-benzyl-N-methyl-1-phenylpyrrolo[1,2-α]pyrazine-3-carboxamide is characterized by the fact that it has improved release in purified water (more than 80%) and 3% sodium lauryl solution ( more than 90%). Examples also show that tablets of N-benzyl-N-methyl-1-phenylpyrrolo[1,2-α]pyrazine-3-carboxamide, obtained using the methods described in this patent, are characterized by a reproducible result for the "Dissolution" test compared to by the method proposed earlier.
EFFECT: disclosed in this patent methods of producing tablets based on N-benzyl-N-methyl-1-phenylpyrrolo[1,2-α]pyrazine-3-carboxamide excludes the step of preparing a binder solution from the production process and thereby simplifying the technology of producing the finished dosage form; also new methods of obtaining are safe from the point of view of toxicology and fire hazard, since the possibility of using organic solvents in the process of producing tablets of N-benzyl-N-methyl-1-phenylpyrrolo[1,2-α]pyrazine-3-carboxamide is excluded.
1 cl, 5 tbl, 6 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF PRODUCING TABLETS OF N-BUTYL-N-METHYL-1-PHENYLPYRROLO[1,2-a]PYRAZINE-3-CARBOXAMIDE | 2023 |
|
RU2831391C2 |
METHOD OF PRODUCING AMORPHOUS SOLID DISPERSION OF N-BUTYL-N-METHYL-1-PHENYLPYRROLO[1,2-A]PYRAZINE-3-CARBOXAMIDE | 2023 |
|
RU2823423C1 |
PHARMACEUTICAL COMPOSITION BASED ON N-BENZYL-N-METHYL-1-PHENYLPYRROLO [1,2-A] PYRAZINE-3-CARBOXAMIDE | 2017 |
|
RU2689396C2 |
PHARMACEUTICAL COMPOSITION BASED ON N-BUTYL-N-METHYL-1-PHENYLPYRROLO[1,2-a]PYRAZINE-3-CARBOXAMIDE | 2023 |
|
RU2811453C1 |
METHOD FOR MAKING SIMVASTATIN-CONTAINING TABLETS | 2002 |
|
RU2214242C1 |
METHOD FOR OBTAINING SOLID MEDICINAL FORM OF PRAVASTATIN-BASED PREPARATION | 2002 |
|
RU2205635C1 |
CARBAMAZEPIN-BASE DRUG | 2001 |
|
RU2189225C1 |
1-ARYLPYRROLO[1,2A]PYRAZINE-3-CARBOXAMIDES WITH NEUROPSYCHOTROPIC ACTIVITY | 2014 |
|
RU2572076C2 |
PHARMACEUTICAL ORAL DOSAGE FORM Q203 | 2020 |
|
RU2829142C1 |
SOLID DOSAGE FORM | 2004 |
|
RU2377987C2 |
Authors
Dates
2024-12-05—Published
2023-07-14—Filed